BACKGROUND A clinical pathway(CP)is a standardized approach for disease management.However,big data-based evidence is rarely involved in CP for related common b
BACKGROUND Non-alcoholic steatohepatitis(NASH)has become one of the leading causes of liver disease in the western world.In obese patients weight reduction is r
BACKGROUND Nonalcoholic fatty liver disease (NAFLD), the most common chronic liver disease, can progress into nonalcoholic steatohepatitis (NASH), cirrhosis, an